Post Profile

Pfizer loses appeal in UK patent case over use of Lyrica drug for pain

LONDON (Reuters) - Pfizer suffered a setback in Britain on Thursday when the Court of Appeal in London ruled against it in a patent case over the use of its $5 billion-a-year drug Lyrica for pain relief.
read more


Related Posts

U.S. court rules AT&T's lawyers too late to appeal patent loss

Business & Finance : Business Insider: Money Game

By Andrew Chung NEW YORK (Reuters) - AT&T Inc was too late to appeal a $40 million loss in a patent infringement case because its lawyers did not read key rulings in time, a federal appeals court said on Thursday. AT&T, which was re...

What Is Lyrica (pregabalin)? What Does Lyrica Treat?

Health : Medical News Today

Lyrica is Pfizer's trade name for a drug called pregabalin. Pregabalin is an anticonvulsant (anti-seizure) drug that is often used to treat neuropathic pain as well as partial seizures that are common in temporal lobe epilepsy. In E...

Pre-roll ads can be patented: appeals court rules in Hulu case

Technology : Gigaom

Opponents of software patents suffered a setback as the Federal Circuit today said a patent for displaying content before a video should not be considered an abstract idea.

Denmark's Genmab looks to immunotherapy for cancer drug encore

Health : Reuters: Health

LONDON (Reuters) - Immunotherapy, which boosts the immune system to fight cancer, could be the next big opportunity for Genmab, potentially driving peak sales of its top-selling drug well past $10 billion a year, its chief executive...

Pfizer Thwarts UK Docs From Prescribing a Drug Over Patent Dispute

Medical / Pharmaceutical : Pharmalot

In a victory for Pfizer, a U.K. court recently ruled that physicians should prescribe generic versions of its Lyrica medicine – but only for treating pain – as the result of an ongoing patent dispute.


Copyright © 2016 Regator, LLC